Grassley questions FDA's 'Safety First'
Sen. Charles Grassley (R-IA) says he is concerned that the FDA's Safety First initiative is merely cosmetic and will not make fundamental changes he says are needed to improve FDA's oversight of approved drugs.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.